Submissions from 2024
Acute kidney injury in neonates with hypoxic ischemic encephalopathy based on serum creatinine decline compared to KDIGO criteria., Haejun C Ahn, Adam Frymoyer, Derek B Boothroyd, Sonia Bonifacio, Scott M Sutherland, and Valerie Y Chock
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial., Stefan R Bornstein, Dick de Zeeuw, Hiddo J L Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine Tuttle, Samy Hadjadj, and Peter Rossing
New and emerging therapies for diabetic kidney disease., Ricardo Correa-Rotter, Louise J Maple-Brown, Rakesh Sahay, Katherine R Tuttle, and Ifeoma I Ulasi
Development and validation of metrics for a new RAPN training model., Rui Jorge Dos Santos Almeida Farinha, Adele Piro, Angelo Mottaran, Marco Paciotti, Stefano Puliatti, Alberto Breda, James Porter, Ben Van Cleynenbreugel, Jos Vander Sloten, Alexandre Mottrie, RAPN-Delphi Surgeons Group, and Anthony G Gallagher
Diabetic Kidney Disease Prevention Care Model Development., Nuha A ElSayed, Raveendhara R Bannuru, George Bakris, Joan Bardsley, Ian H de Boer, Robert A Gabbay, Janet Gockerman, Rozalina G McCoy, Elaine McCracken, Joshua J Neumiller, Scott J Pilla, and Connie M Rhee
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle (EMPA-KIDNEY Collaborative Group)
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial., EMPA-KIDNEY Collaborative Group and Katherine Tuttle
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and Writing team and the World Kidney Day Joint Steering Committee
The authors reply., Winston W S Fung, Valerie A Luyckx, Katherine R Tuttle, and World Kidney Day Joint Steering Committee
Optimizing Care Delivery in Patients with Chronic Kidney Disease in the United States: Proceedings of a Multidisciplinary Roundtable Discussion and Literature Review., Jamie S Hirsch, Samuel Colby Danna, Nihar Desai, Ty J Gluckman, Manisha Jhamb, Kim Newlin, Bob Pellechio, Ahlam Elbedewe, and Evan Norfolk
Incidence and predictors of acute kidney injury after elective surgery for lumbar degenerative disease: A 13-year analysis of the US Nationwide Inpatient Sample., Yueh-Ying Hsieh, Lien-Chen Wu, I-Chun Chen, and Chang-Jung Chiang
Development and Validation of the American Heart Association's PREVENT Equations., Sadiya S Khan, Kunihiro Matsushita, Yingying Sang, Shoshana H Ballew, Morgan E Grams, Aditya Surapaneni, Michael J Blaha, April P Carson, Alexander R Chang, Elizabeth Ciemins, Alan S Go, Orlando M Gutierrez, Shih-Jen Hwang, Simerjot K Jassal, Csaba P Kovesdy, Donald M Lloyd-Jones, Michael G Shlipak, Latha P Palaniappan, Laurence Sperling, Salim S Virani, Katherine Tuttle, Ian J Neeland, Sheryl L Chow, Janani Rangaswami, Michael J Pencina, Chiadi E Ndumele, Josef Coresh, and Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group
Toxin-Induced Liver Injury and Extracorporeal Treatment of Liver Failure., Angela H Lam and Joshua D King
Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease., Christine P Limonte, Julio A Lamprea-Montealegre, and Katherine Tuttle
Mind the Gap in Kidney Care: Translating What We Know Into What We do., Valerie A Luyckx, Katherine Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, and Alessandro Balducci
Mind the Gap in Kidney Care: Translating What We Know Into What We Do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and The World Kidney Day Joint Steering Committee is listed in the Appendix
Mind the gap in kidney care: Translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Mind the gap in kidney care: translating what we know into what we do., Valerie A Luyckx, Katherine R Tuttle, Dina Abdellatif, Ricardo Correa-Rotter, Winston W S Fung, Agnès Haris, Li-Li Hsiao, Makram Khalife, Latha A Kumaraswami, Fiona Loud, Vasundhara Raghavan, Stefanos Roumeliotis, Marianella Sierra, Ifeoma Ulasi, Bill Wang, Siu-Fai Lui, Vassilios Liakopoulos, Alessandro Balducci, and World Kidney Day Joint Steering Committee
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD., Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka, Johannes Stegbauer, Parminder K Judge, David Preiss, Jonathan Emberson, Daniele Trinca, Rejive Dayanandan, Ryonfa Lee, John Nolan, Akiko Omata, Jennifer B Green, David Z I Cherney, Lai Seong Hooi, Roberto Pontremoli, Katherine Tuttle, Jennifer S Lees, Patrick B Mark, Simon J Davies, Sibylle J Hauske, Dominik Steubl, Martina Brückmann, Martin J Landray, Colin Baigent, Richard Haynes, William G Herrington, and EMPA-KIDNEY Collaborative Group
Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease., Brendon L Neuen, Katherine Tuttle, and Muthiah Vaduganathan
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE)., Pablo E Pergola, Michael Davidson, Camilla Jensen, Amir A Mohseni Zonoozi, Dominic S Raj, Philip Andreas Schytz, Katherine Tuttle, and Vlado Perkovic
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes., Vlado Perkovic, Katherine R Tuttle, Peter Rossing, Kenneth W Mahaffey, Johannes F E Mann, George Bakris, Florian M M Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, Richard Pratley, and FLOW Trial Committees and Investigators
Perceptions of Providing Continuous Blood Glucose Data for a Research Study, Teresa Rangel and Rachel Carlson
Universal Fetal Echocardiography for Pregestational Diabetes Mellitus: A Cost-Effectiveness Analysis., Leah M Savitsky, Caitlin Hamilton, Mary Sterrett, Kelsey Olerich, Kimberly Ma, and Catherine M Albright
Association of mental health-related patient reported outcomes with blood pressure in adults and children with primary proteinuric glomerulopathies., Matthew Schuchman, Tammy M Brady, Dorey A Glenn, Katherine Tuttle, Gabriel Cara-Fuentes, Rebecca V Levy, Agustin Gonzalez-Vicente, Fadhl M Alakwaa, Tarak Srivastava, and Christine B Sethna
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today., Howard Trachtman, Hailey Desmond, Amanda L Williams, Laura H Mariani, Sean Eddy, Wenjun Ju, Laura Barisoni, Heather K Ascani, Wendy R Uhlmann, Cathie Spino, Lawrence B Holzman, John R Sedor, Crystal Gadegbeku, Lalita Subramanian, Chrysta C Lienczewski, Tina Manieri, Scott J Roberts, Debbie S Gipson, Matthias Kretzler, NEPTUNE investigators, and Katherine Tuttle (NEPTUNE investigators)
“Adjunctive Therapy in T1D”, Katherine Tuttle
“A Pinch of Salt – A Podcast by ERA”, Katherine Tuttle
“Cardiovascular-Kidney-Metabolic Syndrome, Katherine Tuttle
“Cases in Diabetes, Kidney, and Cardio-Renal-Metabolic Disease”, Katherine Tuttle
CKD screening for better kidney health: Why? Who? How? When?, Katherine Tuttle
“DM and CKD Treatments: Which Treatment Should I Use for Different Populations?”, Katherine Tuttle
“FLOW: Semaglutide scores big in diabetic patients with CKD”, Katherine Tuttle
GLP-1 Receptor Agonists for CKD in Diabetes and Beyond…, Katherine Tuttle
“GLP-1 Receptor Agonists for CKD in Diabetics and Beyond”, Katherine Tuttle
“Glycemic Management in Persons with Diabetes and CKD”, Katherine Tuttle
Helio “Aldosterone inhibitor BI 690517 reduced albuminuria when combined with SGLT2 inhibitor”, Katherine Tuttle
“ Key considerations for tailoring treatment approaches for diabetic patients with chronic kidney disease", Katherine Tuttle
“Kidney Disease and Obesity”, Katherine Tuttle
“Kidney Health for All: Advancing equitable access to care and optimal medication practice”, Katherine Tuttle
“Landmark studies”, Katherine Tuttle
“Miracle weight-loss drugs could halt kidney disease too”, Katherine Tuttle
"National Academies Workshop – Preparing the Future Workforce in Drug andResearch Development", Katherine Tuttle
National Geographic Interview feature article, Katherine Tuttle
“New study shows Ozempic lowers kidney disease”, Katherine Tuttle
“New use for Ozempic”, Katherine Tuttle
“Ozempic cuts risk of chronic kidney disease complications, study finds””, Katherine Tuttle
“Ozempic keeps wowing: trial data show benefits for kidney disease”, Katherine Tuttle
“Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds", Katherine Tuttle
Research Development., Katherine Tuttle
“Semaglutide cuts kidney failure and death in diabetes”, Katherine Tuttle
“Semaglutide significantly improves chronic kidney disease”, Katherine Tuttle
“Success of GLP-1 receptor agonists in kidney disease halts FLOW trial early.”, Katherine Tuttle
“Therapeutic Transformation of Kidney Care – Diabetes and Beyond”, Katherine Tuttle
“Transformation of CKD Care to Delivery Kidney Health”, Katherine Tuttle
“Transforming Kidney Care by Equitable Implementation of Breakthrough Therapies”, Katherine Tuttle
Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis., Katherine Tuttle, Clint W Abner, Patrick D Walker, Kaijun Wang, Andrew Rava, Jihaeng Heo, and Martin Bunke
Clinical Characteristics and Histopathology in Adults With Focal Segmental Glomerulosclerosis., Katherine Tuttle, Clint W Abner, Patrick D Walker, Kaijun Wang, Andrew Rava, Jihaeng Heo, and Martin Bunke
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial., Katherine Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, and Peter Rossing
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial., Katherine R Tuttle, Sibylle J Hauske, Maria Eugenia Canziani, Maria Luiza Caramori, David Cherney, Lisa Cronin, Hiddo J L Heerspink, Christian Hugo, Masaomi Nangaku, Ricardo Correa Rotter, Arnold Silva, Shimoli V Shah, Zhichao Sun, Dorothea Urbach, Dick de Zeeuw, Peter Rossing, and ASi in CKD group
Combination therapy for kidney disease in people with diabetes mellitus., Daniël H van Raalte, Petter Bjornstad, David Z I Cherney, Ian H de Boer, Paola Fioretto, Daniel Gordin, Frederik Persson, Sylvia E Rosas, Peter Rossing, Jennifer A Schaub, Katherine Tuttle, Sushrut S Waikar, and Hiddo J L Heerspink
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study., Chia-Shi Wang, Dorey A Glenn, Margaret Helmuth, Abigail R Smith, Andrew S Bomback, Pietro A Canetta, Gaia M Coppock, Myda Khalid, Katherine Tuttle, Raed Bou-Matar, Larry A Greenbaum, Bruce M Robinson, Lawrence B Holzman, William E Smoyer, Michelle N Rheault, Debbie Gipson, Laura H Mariani, and Cure Glomerulonephropathy (CureGN) Study Consortium
Increasing U.S. Maternal Health Equity Among Immigrant Populations Through Community Engagement., Maryum Zaidi, Heidi Collins Fantasia, Rebecca Penders, Ainat Koren, and Comfort Enah
A framework towards digital twins for type 2 diabetes., Yue Zhang, Guangrong Qin, Boris Aguilar, Noa Rappaport, James T Yurkovich, Lance Pflieger, Sui Huang, Leroy Hood, and Ilya Shmulevich
A new era in the science and care of kidney diseases., Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivek Jha, Carol Pollock, Katherine Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Giuseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, and Raymond Vanholder
Submissions from 2023
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone., Rajiv Agarwal, Bertram Pitt, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Luis M Ruilope, Csaba P Kovesdy, Katherine Tuttle, Muthiah Vaduganathan, Christoph Wanner, Sameer Bansilal, Martin Gebel, Amer Joseph, Robert Lawatscheck, and George L Bakris
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis., Rajiv Agarwal, Wanzhu Tu, Alfredo E Farjat, Youssef M K Farag, Robert Toto, Sanjay Kaul, Robert Lawatscheck, Katja Rohwedder, Luis M Ruilope, Peter Rossing, Bertram Pitt, Gerasimos Filippatos, Stefan D Anker, George L Bakris, FIDELIO-DKD and FIGARO-DKD Investigators, and Katherine Tuttle
“Intensifying Diabetes Therapies to Achieve Personalized Treatment Goals”, Radica Alicic
Incidence of chronic kidney disease in prediabetes, Radica Alicic, Ken Daratha, Joshua J Neumiller, Katherine Tuttle, and See all authors in comments
Author Response to "Insulin Dosing Safety in CKD"., Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease., Radica Alicic, Joshua J Neumiller, and Katherine Tuttle
Incretin Therapies for Patients with Type 2 Diabetes and Chronic Kidney Disease., Radica Z Alicic and Joshua J Neumiller
Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6, SC Bain, Katherine Tuttle, and See Full List of Authors in Comments
Kidney Biopsy Utility: Patient and Clinician Perspectives from the Kidney Precision Medicine Project., Lauren Bernard, Ashley R Wang, Steven Menez, Joel M Henderson, Ashveena Dighe, Glenda V Roberts, Christine Stutzke, Katherine Tuttle, R Tyler Miller, and Kidney Precision Medicine Project
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review., Riccardo Bertolo, Alessio Pecoraro, Umberto Carbonara, Daniele Amparore, Pietro Diana, Stijn Muselaers, Michele Marchioni, Maria Carmen Mir, Alessandro Antonelli, Ketan Badani, Alberto Breda, Ben Challacombe, Jihad Kaouk, Alexandre Mottrie, Francesco Porpiglia, Jim Porter, Andrea Minervini, and Riccardo Campi
A quality improvement initiative to bridge gaps in treatment and interprofessional care of chronic kidney disease, DA Cappel, Katherine Tuttle, and See all authors in comments
Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group)., Clara Cerrato, Margaret F Meagher, Riccardo Autorino, Giuseppe Simone, Bo Yang, Robert G Uzzo, Alexander Kutikov, Francesco Porpiglia, Umberto Capitanio, Francesco Montorsi, James R Porter, Alp T Beksac, Dhruv Puri, Mimi Nguyen, Luke Wang, Kevin Hakimi, Sohail Dhanji, Franklin Liu, Maria A Cerruto, Savio D Pandolfo, Andrea Minervini, Clayton Lau, Aron Monish, Daniel Eun, Alexandre Mottrie, Carmen Mir, Chandru Sundaram, Alessandro Antonelli, Jihad Kaouk, and Ithaar H Derweesh
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group., Clara Cerrato, Devin Patel, Riccardo Autorino, Giuseppe Simone, Bo Yang, Robert Uzzo, Francesco Porpiglia, Umberto Capitanio, James Porter, Alp Tuna Beksac, Andrea Minervini, Alessandro Antonelli, Maria Angela Cerruto, Clayton Lau, Akbar Ashrafi, Daniel Eun, Alexandre Mottrie, Carmen Mir, Margaret F Meagher, Dhruv Puri, Mimi Nguyen, Sohail Dhanji, Franklin Liu, Savio D Pandolfo, Alexander Kutikov, Francesco Montorsi, Inderbir S Gill, Chandru Sundaram, Jihad Kaouk, and Ithaar H Derweesh
Home Dialysis Curriculum Implementation for Health Care Workers Using Project ECHO Principles: A Feasibility Report From NKF-KDOQI., Christopher T Chan, Barbara Dommert-Breckler, Jordan Cannon, Renin Cassidy, Karen Crampton, Danilo Concepcion, Stephanie Hutchinson, Jessica Joseph, Rajnish Mehrotra, Gary Moore, Nancy Pierce, Matthew B Rivara, and Katy Wilkens
Metaverse Surgical Planning with Three-dimensional Virtual Models for Minimally Invasive Partial Nephrectomy., Enrico Checcucci, Daniele Amparore, Gabriele Volpi, Sabrina De Cillis, Federico Piramide, Paolo Verri, Alberto Piana, Michele Sica, Cecilia Gatti, Paolo Alessio, Alberto Quarà, Mariano Burgio, Marco Colombo, Giovanni Busacca, Alex Mottrie, Edward Cherullo, Alberto Breda, Alessandro Antonelli, Renaud Bollens, Andrea Minervini, James R Porter, Riccardo Schiavina, Riccardo Autorino, Ashutosh Tewari, Michele Di Dio, Cristian Fiori, and Francesco Porpiglia
Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network., Dhruti P Chen, Margaret E Helmuth, Abigail R Smith, Pietro A Canetta, Isabelle Ayoub, Krzysztof Mucha, Mahmoud Kallash, Jeffrey B Kopp, Rasheed Gbadegesin, Brenda W Gillespie, Larry A Greenbaum, Rulan S Parekh, Tracy E Hunley, C John Sperati, David T Selewski, Jason Kidd, Aftab Chishti, Kimberly Reidy, Amy K Mottl, Debbie S Gipson, Tarak Srivastava, Katherine E Twombley, CureGN Consortium, and Katherine Tuttle
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study., Toni K Choueiri, David F McDermott, Jaime Merchan, Todd M Bauer, Robert Figlin, Elisabeth I Heath, M Dror Michaelson, Edward Arrowsmith, Anishka D'Souza, Song Zhao, Ananya Roy, Rodolfo Perini, Donna Vickery, and Scott S Tykodi
Empagliflozin in Patients with Chronic Kidney Disease., The EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine R Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, Radica Alicic, Ann Cooper, and Lisa Davis
Tirzepatide decreases systolic and diastolic blood pressure., Sidar Copur, Atalay Demiray, David Cherney, Katherine Tuttle, and Mehmet Kanbay
Tirzepatide and potential use for metabolically healthy obesity., Sidar Copur, Cem Tanriover, Furkan Yavuz, Katherine R Tuttle, and Mehmet Kanbay
Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury?, Sidar Copur, Abdullah Yildiz, Carlo Basile, Katherine R Tuttle, and Mehmet Kanbay
Needs Assessment: Characterizing resident knowledge gaps in inpatient care of persons with Cystic Fibrosis to inform a quality improvement educational intervention, S Eglin, M Drobny, and AA Lambert
Empagliflozin in Patients with Chronic Kidney Disease., EMPA-KIDNEY Collaborative Group, William G Herrington, Natalie Staplin, Christoph Wanner, Jennifer B Green, Sibylle J Hauske, Jonathan R Emberson, David Preiss, Parminder Judge, Kaitlin J Mayne, Sarah Y A Ng, Emily Sammons, Doreen Zhu, Michael Hill, Will Stevens, Karl Wallendszus, Susanne Brenner, Alfred K Cheung, Zhi-Hong Liu, Jing Li, Lai Seong Hooi, Wen Liu, Takashi Kadowaki, Masaomi Nangaku, Adeera Levin, David Cherney, Aldo P Maggioni, Roberto Pontremoli, Rajat Deo, Shinya Goto, Xavier Rossello, Katherine Tuttle, Dominik Steubl, Michaela Petrini, Dan Massey, Jens Eilbracht, Martina Brueckmann, Martin J Landray, Colin Baigent, Richard Haynes, and The EMPA-KIDNEY Collaborative Group
Objective assessment of intraoperative skills for robot-assisted partial nephrectomy (RAPN)., Rui Farinha, Alberto Breda, James Porter, Alexandre Mottrie, Ben Van Cleynenbreugel, Jozef Vander Sloten, Angelo Mottaran, and Anthony G Gallagher
Efficacy, and safety of remdesivir in people with moderately and severely reduced kidney function hospitalized for COVID-19: The REDPINE study, JRS Fernandez, Katherine Tuttle, and See full list of authors in comments
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD., Rodolfo J Galindo, Ian H de Boer, Joshua J Neumiller, and Katherine R Tuttle
National Trends in Glucagon Prescriptions Among U.S. Adults With Diabetes and End-Stage Kidney Disease Treated by Dialysis: 2013-2017., Rodolfo J Galindo, Shealeigh A Inselman, Guillermo E Umpierrez, Bobak Moazzami, Jair Munoz Mendoza, Mohammed K Ali, Katherine R Tuttle, and Rozalina G McCoy
960-P: Hemodialysis-Related Glycemic Patterns among People with Insulin-Treated Type 2 (T2D) Diabetes—Role of Continuous Glucose Monitoring (CGM), Rodolfo J. Galindo, Katherine Tuttle, and See full list of authors in comments
Long COVID and the Heart, Tyler Gluckman
Temporal Shifts In Guideline-directed Medical Therapy Prescribed At Discharge To Heart Failure Patients In A Large US Integrated Health System, Tyler Gluckman, ST Chiu, J Remick, and See full list of authors in comments
People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action., Hiddo Jl Heerspink, David Zi Cherney, Per-Henrik Groop, Chantal Matthieu, Peter Rossing, Katherine R Tuttle, and Janet B McGill
